No matter where you are on your recovery journey, BRIXADI may be an option for you

Why BRIXADI?

BRIXADI is a long-acting injection that contains buprenorphine. Buprenorphine has been used to treat opioid use disorder (OUD) for many years. It can help reduce opioid use by attaching to opioid receptors in the brain. As a result, opioids are less likely to attach, and the rewarding effects of opioids are blocked.

BRIXADI is available in once-a-week and once-a-month doses.

The medicine is steadily released in your body throughout the entire week or month.You and your healthcare provider can choose which dose is right for you.

weekly and monthly calendar icons

Your healthcare provider may consider BRIXADI if:

  • You are already taking buprenorphine for OUD, such as a daily dissolvable tablet or as a film. In that case, you can switch directly to BRIXADI
  • You are not currently taking a buprenorphine treatment for OUD. In that case, your healthcare provider will give you a test dose of buprenorphine as a dissolvable tablet or film before starting you on a weekly injection of BRIXADI

BRIXADI should be used as part of a complete treatment plan that includes counseling and behavioral therapy.

Consoling Man on BedConsoling Man on Bed

Buprenorphine is released at a steady rate

BRIXADI is injected with a small needle just under the skin (subcutaneously) by a healthcare provider as a liquid. After the injection, BRIXADI changes to a gel form called a depot. The depot is not always felt under the skin. The depot slowly releases buprenorphine into your body throughout the entire week or month at a steady rate. This means that the medicine is released all week or month without daily ups and downs. The graphs below show the level of buprenorphine in the blood at steady state (after 4 doses in a row).

Chart showing the weekly levels of BRIXADI in the blood
Chart showing the mothly levels of BRIXADI in the blood
WeeklyToggle switch iconMonthly
zoom icon

Pinch to zoom

SL, sublingual (under the tongue).

Model based on 236 subjects and greater than 10,000 observations from 4 clinical studies.

What do we know from clinical studies?

Clinical studies were done to understand the safety profile and effectiveness of BRIXADI. The goal of the main clinical study was to see how results with BRIXADI compared to results with daily oral buprenorphine-naloxone. The study was comprised of 428 patients with moderate to severe OUD. These patients were using heroin, fentanyl, or other opioids.

pill icon

The study participants were given BRIXADI or a sublingual tablet of buprenorphine-naloxone and individual drug counseling. They were also given a placebo injection or placebo daily sublingual tablet so they did not know what medication they were receiving.

arrow down icon

BRIXADI helped patients reduce illicit opioid use and was not inferior to daily oral buprenorphine-naloxone in doing so.

What are the possible side effects of BRIXADI?

BRIXADI has similar side effects to oral buprenorphine. There can also be mild to moderate side effects related to the injection.

In the clinical studies, the most common side effects were:

  • Injection
    site pain
  • Headache
  • Constipation
  • Nausea
  • Injection site
    redness
  • Injection site
    itching
  • Insomnia
  • Urinary tract
    infections

These are not all the possible side effects of BRIXADI. Tell your healthcare provider if you experience any side effects from BRIXADI.

smiling confident woman smiling confident woman
exclamation mark icon

Find key information on BRIXADI.

Download resource button

Download the Patient Brochure

Understanding OUD

Is BRIXADI Right for Me?

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about BRIXADI?

  • Because of the serious risk of potential harm or death from self-injecting BRIXADI into a vein (intravenously), it is only available through a restricted program called the BRIXADI Risk Evaluation and Mitigation Strategy (REMS) Program.
    • BRIXADI is not available in retail pharmacies.
    • Your BRIXADI injection will only be given to you by a healthcare provider.
  • BRIXADI (buprenorphine) extended-release injection for subcutaneous use contains a medicine called buprenorphine. Buprenorphine is an opioid that can cause serious and life-threatening breathing problems, especially if you take or use certain other medicines or drugs.
  • Talk to your healthcare provider about naloxone. Naloxone is a medicine that is available to patients for the emergency treatment of an opioid overdose. If naloxone is given, you must call 911 or get emergency medical help right away to treat an overdose or accidental use of an opioid.
  • BRIXADI can cause serious and life-threatening breathing problems. Get emergency help right away if you:
    • feel faint
    • feel dizzy
    • are confused
    • feel sleepy or uncoordinated
    • have blurred vision
    • have slurred speech
    • are breathing slower than normal
    • cannot think well or clearly
  • Do not take BRIXADI with certain medicines. Taking BRIXADI with other opioid medicines, benzodiazepines, alcohol, other central nervous system depressants (including street drugs) can cause severe drowsiness, decreased awareness, breathing problems, coma, and death.
  • In an emergency, have family members tell the emergency department staff that you are physically dependent on an opioid and are being treated with BRIXADI.
  • You may have detectable levels of BRIXADI in your body for several months after stopping treatment with BRIXADI.

Do not receive BRIXADI if you are allergic to buprenorphine or any ingredients in BRIXADI:

  • BRIXADI weekly: anhydrous ethanol, soybean phosphatidylcholine, glycerol dioleate
  • BRIXADI monthly: N-methylpyrrolidone, soybean phosphatidylcholine, glycerol dioleate

Before receiving BRIXADI, tell your healthcare provider about all of your medical conditions, including if you have:

  • Trouble breathing or lung problems
  • A curve in your spine that affects your breathing
  • Addison’s disease
  • An enlarged prostate (men)
  • Problems urinating
  • Liver, kidney, or gallbladder problems
  • A history of alcoholism
  • A head injury or brain problem
  • Mental health problems
  • Adrenal gland or thyroid gland problems
  • A latex allergy. The BRIXADI needle cap contains latex.

Tell your healthcare provider if you are:

  • pregnant or plan to become pregnant. If you receive BRIXADI while pregnant, your baby may have symptoms of opioid withdrawal at birth that could be life-threatening if not recognized and treated. Talk to your healthcare provider if you are pregnant or become pregnant.
  • breastfeeding. BRIXADI can pass into your breast milk and may harm your baby. Talk to your healthcare provider about the best way to feed your baby during treatment with BRIXADI. Monitor your baby for increased drowsiness and breathing problems if you breastfeed during treatment with BRIXADI.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. Talk with your healthcare provider before starting any new medicines during or after stopping treatment with BRIXADI.

What should I avoid while receiving BRIXADI?

  • Do not drive, operate heavy machinery or perform any other dangerous activities until you know how BRIXADI affects you. BRIXADI can cause drowsiness and slow reaction times. BRIXADI can make you sleepy, dizzy, or lightheaded. This may happen more often in the first few days after your injection and when your dose is being changed.
  • You should not drink alcohol or use prescription or over-the-counter medicines that contain alcohol during treatment with BRIXADI, because this can lead to loss of consciousness or even death.

What are the possible side effects of BRIXADI?

BRIXADI can cause serious side effects, including:

  • Trouble breathing. Taking BRIXADI with other opioid medicines, benzodiazepines, alcohol, or other central nervous system depressants can cause breathing problems that can lead to coma and death.
  • Sleepiness, dizziness, and problems with coordination.
  • Physical dependence or abuse.
  • Liver problems. Call your healthcare provider right away if you notice any of these symptoms:
    • your skin or the white part of your eyes turns yellow (jaundice)
    • dark or “tea-colored” urine
    • light-colored stools (bowel movements)
    • loss of appetite
    • pain, aching, or tenderness on the right side of your stomach area
    • nausea

      • Your healthcare provider should do tests to check your liver before and during treatment with BRIXADI.

  • Allergic reaction. You may have a rash, hives, swelling of your face, wheezing, light-headedness when changing positions, feeling faint, or loss of consciousness. Call your healthcare provider or get emergency help right away.
  • Opioid withdrawal. Call your healthcare provider right away if you get any of these symptoms:
    • shaking
    • sweating more than normal
    • feeling hot or cold more than normal
    • runny nose
    • watery eyes
    • goose bumps
    • diarrhea
    • vomiting
    • muscle aches

    These symptoms may start weeks to months after your last dose of BRIXADI. Tell your healthcare provider if you develop any of these symptoms.

  • Decrease in blood pressure. You may feel dizzy if you get up too fast from sitting or lying down.
  • The most common side effects of BRIXADI include: injection site pain, headache, constipation, nausea, injection site redness, injection site itching, trouble sleeping (insomnia), and urinary tract infection.

BRIXADI may affect fertility in males and females. Talk to your healthcare provider if this is a concern for you.

These are not all the possible side effects of BRIXADI. Call your healthcare provider for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

For more information about BRIXADI, ask your healthcare provider or go to www.BRIXADI.com or call 1-833-274-9234.

This information does not take the place of talking with your healthcare provider for medical advice about your condition or treatment.

Please see BRIXADI Medication Guide and Full Prescribing Information, including BOXED WARNING.

What is BRIXADI?

BRIXADI is a prescription medicine used to treat moderate to severe opioid addiction (dependence) to opioid drugs (prescription or illegal) in people:

  • who have started treatment with a single dose of a buprenorphine medicine in the form of a sublingual tablet or buccal film (transmucosal), OR
  • who are already being treated with buprenorphine

BRIXADI should be used as part of a complete treatment plan that also includes counseling and behavioral therapy.

You are now leaving BRIXADI.com

The link you clicked will take you to a site maintained by a third party, who is solely responsible for its content. Braeburn Inc. does not control, influence nor endorse the site.